TAS-102 has been shown to exert its anti-tumor immune effects primarily by directly eliminating tumor-associated macrophage 2 (TAM2) and promoting tumor growth through mechanisms such as angiogenesis and immunosuppression [42, 43]. Here, ORAI1 is linked to neoplasm.